Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells
about
Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-kappaB activation.Hodgkin's lymphoma and CD30 signal transductionThe enteropathogenic E. coli (EPEC) Tir effector inhibits NF-κB activity by targeting TNFα receptor-associated factorsHypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma.The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma.Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associatRIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.Ubiquitin chains in the ladder of MAPK signaling.Two distinct signalling cascades target the NF-kappaB regulatory factor c-IAP1 for degradation.The role of NF-kappaB in lymphoid malignancies.The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape.Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.Ascorbate promotes epigenetic activation of CD30 in human embryonic stem cells.TRAF2 phosphorylation modulates tumor necrosis factor alpha-induced gene expression and cell resistance to apoptosis.Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeutics.A novel NF-kappaB inhibitor DHMEQ selectively targets constitutive NF-kappaB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo.Phosphorylation of TRAF2 within its RING domain inhibits stress-induced cell death by promoting IKK and suppressing JNK activation.Brentuximab vedotin: clinical updates and practical guidance.TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.NF-κB in Hematological Malignancies.Genetic Alterations of TRAF Proteins in Human Cancers
P2860
Q24811356-A2A3012F-3F10-462C-9898-C11A2C835036Q28207526-05679347-DF11-4CB7-801F-BB0D0C0AE4A4Q28478223-0F6ECEB5-BDB2-4FA2-A55A-71C07AA76758Q34707404-BB828C77-024E-4F85-B5B5-30520669DA28Q35140197-8B296A06-EFB7-4F97-854F-B646901D4A4EQ35757197-58ED23AD-41D5-41CF-91CE-EB8D22886D4AQ36033375-E42DF77A-E378-4964-A960-359BDC502780Q36108376-8F106196-9ACF-4018-9C08-A455B9C6CF28Q37179796-4EAB0529-B1D4-4FDA-AEB7-A95C7FBF8B08Q37198020-6554E75A-79AD-458A-A820-60843BD84A60Q37763027-44839C59-A3AE-4EE3-B9A9-AB53E7BC22CBQ39318861-8388EE2C-F9F1-41BE-8F6F-C93AEBA3E45CQ39392332-BFD0F7D0-EB42-4D0C-97F1-E2C7E75D82DDQ39666693-83136F25-F5CB-43E5-BC12-78C918BEFBCBQ39921849-3F8612AB-E978-4C03-B74C-66E0CCEFD890Q40392451-99FFA35B-02B3-46B1-8566-7FF3FDAA09D4Q40496335-4176C885-4FFC-4EAC-BC1A-278AFDF6981BQ42451661-4CB269E3-C333-405B-BFFD-AD2C95E191B0Q49282959-83DBDDA2-5871-4F9B-993D-DE6BA4C7B65DQ50335956-6AF8F055-FD35-42D6-BEB6-E9912F934E36Q54147337-428259DA-127F-48E0-A58B-F529BD17170FQ57191736-41447BEE-D57E-4BD1-B4E4-174313865DB9
P2860
Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells
@en
type
label
Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells
@en
prefLabel
Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells
@en
P2093
P2860
P1476
Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells
@en
P2093
Mariko Watanabe
Marshall Kadin
Masaaki Higashihara
Ryouichi Horie
Takaomi Ishida
Takuro Watanabe
Toshiki Watanabe
Yasuyuki Morisita
P2860
P304
P356
10.1016/S0002-9440(10)61112-1
P407
P577
2002-05-01T00:00:00Z